Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06214923 · ClinicalTrials.gov registry record · NA

Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)

A NA study of Pain and Virtual Reality, sponsored by University of Maryland, Baltimore.

Recruiting
Registry status
NA
Development phase
78
Enrollment target
2
Study locations

NCT06214923 is a NA study of Pain and Virtual Reality that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 78 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (74% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06214923, a NA study of Pain and Virtual Reality, is actively recruiting participants, sponsored by University of Maryland, Baltimore.

RECRUITING
Registry status
NA
Development phase
78 participants
Enrollment target
2
Study locations

Study Summary

This project examines, in chronic pain, the mechanisms of immersive virtual reality compared to the mechanisms of placebo hypoalgesia. The potential of developing new non-pharmacological premises for low-risk interventions for pain management is high.

Interventions

  • DEVICE RelieVRx
  • DEVICE Sham-VR
  • OTHER No-VR (natural history control)

Study Locations (2)

Maryland

  • Luana Colloca - Baltimore
  • University of Maryland - Baltimore

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2024-04-09
Est. Completion 2026-11-30
Phase NA

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT06214923

The ClinicalTrials.gov registry entry for NCT06214923 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (74% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Pain appearing as the primary indexed condition, and to 3 interventions - of which RelieVRx is the first listed.

NCT06214923 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06214923 about?

NCT06214923 is a clinical study titled "Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)". This project examines, in chronic pain, the mechanisms of immersive virtual reality compared to the mechanisms of placebo hypoalgesia. The potential of developing new non-pharmacological premises for low-risk interventions for pain management is high.

What is the current status of trial NCT06214923?

This trial is currently recruiting. It is a NA study. The enrollment target is 78 participants. The study started on 2024-04-09. Estimated completion is 2026-11-30.

What conditions does trial NCT06214923 study?

This clinical trial studies the following conditions: Pain, Virtual Reality, Placebo, Temporomandibular Disorder.

What interventions are being tested in trial NCT06214923?

The interventions under investigation include: RelieVRx (DEVICE), Sham-VR (DEVICE), No-VR (natural history control) (OTHER).

Who is sponsoring clinical trial NCT06214923?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06214923 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.